Leveraging insights from OpenAI’s ChatGPT, Finbold has curated a $1,000 stock portfolio designed to capture growth ...

Four years ago, dozens of companies denounced the invasion of the U.S. Capitol and pledged to withhold support from those who ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 502.93% and ...

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...

Pfizer's oncology promises are several years from being actualized. Read why investors shouldn't assume that a sustained ...

The Japanese company urged Biden to reflect on the steps it has taken to address national-security concerns. One crew member was in intensive care after engine problems and smoke in the cabin and ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

Differences in how men and women manifest and experience psoriatic arthritis suggest it’s time to think of patient sex as a ...

Novo Nordisk ADR (NYSE: NVO) currently trades at $89 per share, nearly 40% below its peak level of over $145 seen in June of ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...

Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat ...